`
NEW YORK, March 24, 2025 — The Gross Law Firm is notifying shareholders of ESSA Pharma Inc. (NASDAQ: EPIX) about an upcoming deadline.
The firm encourages shareholders who acquired EPIX shares during the specified period to reach out regarding the possibility of serving as a lead plaintiff. Participation in any potential recovery is not contingent on being appointed as lead plaintiff.
CONTACT US HERE:
CLASS PERIOD: December 12, 2023 to October 31, 2024
ALLEGATIONS: The lawsuit claims that during the class period, the defendants made materially false and misleading statements or failed to disclose that: (i) masofaniten combined with enzalutamide did not demonstrate a clear advantage in efficacy compared to enzalutamide alone; (ii) consequently, masofaniten combined with enzalutamide was less effective for prostate cancer treatment than the defendants led investors to believe; (iii) the M-E Combination Study, which examined monotherapy and combination therapy for prostate cancer, was unlikely to achieve its predetermined Phase 2 primary endpoint; (iv) as a result, the defendants overstated the clinical, regulatory, and commercial potential of masofaniten; and (v) therefore, the defendants’ public statements were materially false and misleading throughout the relevant period.
DEADLINE: March 25, 2025. Shareholders should register for this class action without delay. Register your information here:
NEXT STEPS FOR SHAREHOLDERS: Upon registering as a shareholder who purchased EPIX shares during the aforementioned period, you will be enrolled in portfolio monitoring software that will provide you with updates on the case’s status. The deadline to apply for lead plaintiff status is March 25, 2025. Participation in this case involves no cost or obligation.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized firm specializing in class action lawsuits, dedicated to safeguarding the rights of investors who have suffered losses due to deception, fraud, and unlawful business practices. The Gross Law Firm aims to ensure companies uphold responsible business conduct and practice good corporate citizenship. The firm pursues recovery for investors who experienced losses due to false or misleading statements, or omissions of important information by a company that led to artificial inflation of the company’s stock price. Attorney advertising. Previous results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email:
Phone: (646) 453-8903
SOURCE Gross Law Firm